Janus Henderson Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Hold |
37,000
| – | – | ﹤0.01% | 2119 |
|
|
2025
Q1 | $322K | Buy |
+37,000
| New | +$322K | ﹤0.01% | 2172 |
|
|
2024
Q2 | – | Sell |
-32,213
| Closed | -$164K | – | 2529 |
|
|
2024
Q1 | $164K | Buy |
32,213
+4
| +0% | +$20 | ﹤0.01% | 2457 |
|
|
2023
Q4 | $300K | Sell |
32,209
-64
| -0.2% | -$596 | ﹤0.01% | 2240 |
|
|
2023
Q3 | $212K | Buy |
32,273
+8
| +0% | +$52 | ﹤0.01% | 2355 |
|
|
2023
Q2 | $262K | Sell |
32,265
-25
| -0.1% | -$203 | ﹤0.01% | 2330 |
|
|
2023
Q1 | $277K | Buy |
32,290
+18,720
| +138% | +$161K | ﹤0.01% | 2318 |
|
|
2022
Q4 | $126K | Sell |
13,570
-13,570
| -50% | -$126K | ﹤0.01% | 2290 |
|
|
2022
Q3 | $280K | Buy |
27,140
+13,593
| +100% | +$140K | ﹤0.01% | 2244 |
|
|
2022
Q2 | $136K | Sell |
13,547
-10
| -0.1% | -$100 | ﹤0.01% | 2416 |
|
|
2022
Q1 | $167K | Buy |
+13,557
| New | +$167K | ﹤0.01% | 2483 |
|